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Abstract
Much of medical research relies on animal models to deepen knowledge of the causes of animal and human diseases, as
well as to enable the development of innovative therapies. Despite rodents being the most widely used research model
worldwide, in recent decades, the use of the zebrafish (Danio rerio) model has exponentially been adopted among the
scientific community. This is because such a small tropical freshwater teleost fish has crucial genetic, anatomical
and physiological homology with mammals. Therefore, zebrafish constitutes an excellent experimental model for
behavioral, genetic and toxicological studies which unravels the mechanism of various human diseases.
Furthermore, it serves well to test new therapeutic agents, such as the safety of new vaccines. The aim of this
review was to provide a systematic literature review on the most recent studies carried out on the topic. It
presents numerous advantages of this type of animal model in tests of efficacy and safety of both animal and
human vaccines, thus highlighting gains in time and cost reduction of research and analyzes.
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Introduction
The role of the immune system is to protect a body
against bacterial, viral, or any foreign antigen invasions. In
order to improve protection, vaccination is used to boost
immunity against diseases caused by microorganisms. It
typically contains a less virulent agent that triggers a reac-
tion, thus, stimulating a body’s immune system to
recognize it as foreign. In the process, a body’s defense
mechanism learns to recognize and destroy a microorgan-
ism, its toxins or surface proteins [94] every time an inva-
sion is identified. The use of vaccination is important
because it promotes the stimulation of the body’s defense
mechanisms and the development of both individual and
collective immunity. Vaccination can act on specific
(adaptive) and nonspecific (innate) immune responses
unlike immunostimulants which only act on innate re-
sponse. In addition, it should be noted the role vaccines
play in controlling diseases as preventative as well as non-
therapeutic measures. Therefore, the body is able to pro-
duce antibodies that recognize, signal and neutralize path-
ogens or particular cellular responses which detect the
specific antigens with high efficiency and affinity. As a re-
sult, vaccines protect the body against future infections
[27] thus reducing the need for the use of antibiotics and
other types of drugs.
Despite the study of immunology in fish being more recent
compared to those of humans and in animals, the concepts
and techniques used are similar [60]. The study of the use of
vaccines in fish is an area of fast-growing. As aquaculture ex-
pands and the need to control pathogens becomes more
pressing, the commercial vaccination of different varieties of
fish is already a reality in many countries. It aids in the pre-
vention of diseases that could pose health risks to the shoal
as well as in avoiding the economic losses due to mortality
caused by infection. It reduces the contamination of water
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bodies by the excessive use of antibiotics, and the reduction
of final fish product quality [5, 24, 42, 79, 100].
The Zebrafish model has been widely used in both ani-
mal and human health research and, more recently, in
aquaculture too. In spite of rodents being the most
widely used research model in the world, in recent de-
cades the use of the zebrafish (Danio rerio) model has
exponentially increased among the scientific community.
It follows the principle of 3Rs (replacement, reduction,
and refinement) as required by a multiplicity of national
and international regulatory bodies. Furthermore, the
use of zebrafish model results in a reduction of time and
use of resources when compared to those more estab-
lished animals’ models. It also provides a greater infor-
mational and predictive capacity when compared to
in vitro results [53]. Thus, using the zebrafish model, it
is possible to replace and reduce the use of mammals in
research as well as mitigate problems related to the wel-
fare of those animals. Furthermore, zebrafish is used as
confirmatory models of the positive previously obtained
results, thus, having the ability to refine the findings [2].
A review of the literature was carried out aiming at pre-
senting the most recent information on vaccination of
fish, which brings to light the advantages of this animal
model in tests of efficacy and safety of both animal and
human vaccines.
Material and methods
The present study was based on a systematic literature re-
view carried out using databases such as Science Direct,
Google Scholar and SciELO (Scientific Electronic Library
Online). Emphasis was given on identifying publications
using search words and terms containing ‘human vaccin-
ation’ and ‘animal vaccination’. Particularly, the main key-
words searched included ‘Zebrafish model’, ‘vaccine
safety’, ‘diseases’, ‘infection’ and ‘toxicology’. Initially, 99
publications were identified which included books, rulings
and articles published by international scientific journals
of high impact factor. The publications were selected ac-
cording to relevance and timeliness. 19% of the articles
used were published in the last year, 65% in the last 5
years, and 89% published in the last 10 years.
Discussion
Zebrafish model and vaccines testing
Vaccination safety
When devising immunization experiments, challenge tri-
als for vaccine development evaluate the efficacy and
safety of the vaccine against different pathogens. These
are normally assessed using animal models, mainly mam-
mals, which are often imprecise in reflecting human dis-
eases [93], not to mention time consuming, and require a
large number of animals. Moreover, the mortality and
clinical signs as well as laboratory tests are usually
analyzed to evaluate the innate (non-specific) or adaptive
(specific) immune system response. As in mammals, Zeb-
rafish has a well-maintained adaptive immune system
composed of T and B lymphocytes that develop from the
thymus and kidneys respectively. However, in relation to
the development of memory lymphocytes, fish seem to
have memory cells of the type B and T [78]. Yet, there has
not been enough data to confirm that in Zebrafish. Zebra-
fish also presents the enzyme system involved in the
process of genetic rearrangement that originates the B
(BCR) and T (TCR) lymphocyte receptors. As in humans,
Zebrafish has recombination activator genes that control
the rearrangement of gene segments V, D and J to pro-
duce the diversity of antibodies and lymphocyte receptors.
In addition, the zebrafish’s immune system has only ap-
proximately 300,000 antibody-producing B cells, making it
three orders of magnitude smaller than mice and five or-
ders simpler than humans [48].
The efficiency of the humoral response increases due
to the increased affinity of the antibodies. Affinity mat-
uration of antibody responses is less efficient in cold-
blooded vertebrates compared to mammals. Despite this,
in zebrafish, data revealed that specific nucleotides in re-
gions of the BCR receptor were target of directed muta-
tions. Therefore it was suggested that activation-induced
deaminase and affinity maturation contributed to the di-
versification of antibodies also in fish [56]. Immunization
of teleost fish with the TNP-KLH antigen (linked to tri-
nitrophenyl to keyhole limpet hemocyanin), for example,
induced the production of specific low affinity anti-
bodies, which were replaced in 5 weeks by antibodies of
intermediate affinity, and after 15 weeks, by antibodies
with greater affinity for the antigen [28, 97].
Among the immunological tests, the most frequent ones
are: complete hematological analysis by counting erythro-
cytes; thrombocytes and leukocytes; differential white cell
count; hematocrit; glucose; organ histology, and immuno-
logical essays such as serology, specific antibody titration,
and agglutination [4, 29, 57]. Furthermore, toxicity tests
can be also conducted using zebrafish such as embryotoxi-
city, hepatotoxicity, neurotoxicity, endocrine toxicity, gen-
otoxicity, among others as proposed by Bailone et al. [3].
Up to now, these tests have been conducted using ro-
dents, but in recent decades, the Zebrafish model has
proved to be an important tool in the studies of infec-
tions and immunological responses. This model has the
advantage of having OECD-specific guidelines for safety
evaluation of chemical compounds (acute toxicity),
which is performed within 96 h [65]. In addition, obser-
vations can be made in real-time allowing for the moni-
toring of embryogenesis (Fig. 1) as well as regarding the
effects of vaccines in relation to cardiovascular, hepatic,
nervous, and endocrine, not to mention, behavioral
aspects too [18, 40].
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Prior to vaccines being tested on humans, livestock or
pets, these should be assessed using animal models to
avoid causing them harm, including death, especially in
the case of immunosuppressed organisms, children and
the elderly [26]. As for vaccination in humans, for ex-
ample, about 0.4 to 1.9 people per million who had been
vaccinated with BCG against tuberculosis may have de-
veloped the disease through vaccine contagion. For
hepatitis B, 1 in 600,000 people vaccinated may have
presented a severe allergic reaction (anaphylaxis). In the
case of vaccine against poliomyelitis, vaccine contagion
happened to 1 in every 3.6 million vaccinated. Moreover,
to combat yellow fever, the vaccine contagion and sei-
zures happened to 1 in 22 million and internal hemor-
rhages happened to 1 in 450,000. Thence, the
occurrence of side effects is very rare. Side effect reac-
tions in humans may also be observed to be caused by
other vaccines such as yellow fever, measles, mumps, ru-
bella, chicken pox, diphtheria and tetanus. The most
common symptoms are seizures, severe allergic reac-
tions, meningitis, encephalitis [26]. Although these risks
are irrelevant when compared to damages that could be
caused by the non-use of a vaccine, the toxicology, the
side effects and immunization at different concentrations
ought to be adequately tested.
Thus, the Zebrafish model has the advantage of a re-
searcher to follow in real-time the fish’s development
from its embryogenesis to full organ development which
is reached about 36 h after fertilization. This allows for a
vaccine’s effect on all the major organs precursors to be
closely studied [53] such as using immunohistology
(Fig. 2).
Zebrafish and mammalian toxicity (Lethal concentra-
tion – LC50) profiles are surprisingly similar for a range
of substances specified in Table 1 below. Therefore, tox-
icity studies support the effectiveness of using the zebra-
fish model for the purpose of testing these substances.
Furthermore, they can be extrapolated to the active in-
gredients present in the vaccine, and enabling quick par-
allel studies of vaccine reactions in humans and
zebrafish.
Advantages of zebrafish model in vaccination tests
Compared to other vertebrates, zebrafish have extra bio-
logical advantages including high fecundity, external
fertilization, optical transparency and rapid development.
Moreover, Zebrafish possess a highly developed immune
system that is remarkably similar to the human one.
Therefore, it is expected that the majority of the signal-
ing pathways and molecules involved in the immune re-
sponse of mammals would also exist and behave
similarly in fish [89]. Consequently, the presence in fish
of elements of innate and adaptive immunity enables re-
search in infectious processes, being susceptible to infec-
tions by gram-negative and gram-positive bacteria,
protozoa, viruses, fungi and mycobacteria.
The development of special cloning, mutagenesis and
transgenesis techniques allowed the identification of a
significant number of mutants. Commercial mutant zeb-
rafish lines and the recently developed CRISPR/Cas9
genome modification system provide the means to create
knockout zebrafish for studying individual genes at a
whole organism level [66]. Non-pigmenting mutants
such as Casper zebrafish have also helped improve visi-
bility of internal organs [92]. In addition it is easy to
generate transgenic zebrafish with ‘reporter genes’ to fa-
cilitate analysis in live fish [87]. Because the zebrafish
genome is conserved in humans, information obtained
Fig. 1 Embryos of zebrafish 0, 6, 24 and 48 h’ post-fertilization. Larvae of zebrafish 72 and 96 h post-fertilization
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from zebrafish studies may lead to translational results
in humans [38].
Examples of mutant animals displaying human-like
diseases are numerous such as: sapje, which has the gene
homologous to that of Duchenne muscular dystrophy;
dracula, related to erythropoietic protoporphyria; van
Gogh, model of the DiGeorge syndrome; and gridlock,
which induces coarctation of the aorta [47]. Research in
tumor suppressor genes p53 and apc (adenomatous
polyposis coli) is another area of great interest. The im-
portance of the p53 gene in human carcinogenesis is
well recognized and recent studies have shown zebrafish
as an excellent model for assessing the presence (or not)
of gene stability. Lymphoid leukemia, melanoma and
hepato-carcinoma have already been described in zebra-
fish thus confirming that the molecular mechanisms in-
volved are similar to those of humans [49].
Regarding the administration of vaccines, in view of
the different routes of applications presented in animals
and humans, the zebrafish model still allows the
immunization of embryos, facilitated by its transparency,
using glass needles (Figs. 3 and 4). Interestingly, the fact
that the fish’s adaptive immune system does not reach
maturity up to 4 weeks after fertilization allows them to
be used without the need for immunosuppression in the
embryonic stages [32] in the case, for example, of tumor
xenograft experiments.
In zebrafish larvae, a rapid systemic infection can be
initiated by direct microinjection of a bacterial suspen-
sion into the bloodstream. Alternatively, a more local-
ized infection may be induced by the injection of
microbes into the muscle tail or the hindbrain ventricle
[6]. For high transfer rate, the microbes can be readily
injected into the yolk for the first few hours after
fertilization. However, it is important to keep in mind
that the yolk lacks immune cells, and therefore the bac-
teria are able to grow freely before invading the larval
tissues [51].
Several transgenic zebrafish lines containing fluores-
cent markers in different cells of the immune system
have been developed to visualize host-microbe interac-
tions in the transparent larvae. For example, recruitment
of fluorescent neutrophils to the site of bacterial infec-
tion (which can also be labeled with fluorescence) could
be easily followed and quantified in real time. Yet, so far,
researchers have focused primarily on larval infection
patterns [51].
Fish vaccines
In the prevention of disease outbreaks causing mortal-
ities in aquaculture, similarly to any other animal pro-
duction system, vaccination is essential. Thus, the use of
vaccines for that purpose could be improved based on
the results from the studies performed in zebrafish [89].
The development of vaccines for aquaculture has been
an important milestone for guaranteeing a continuous
safe and high standard animal health production system.
In recent years, zebrafish models have been chosen as
the preferred model in the production of fish vaccination
experiments against several pathogens that cause losses
in aquaculture around the world such as bacteriosis and
viruses. One of the most important pathogen studies
Fig. 2 Histology of adult zebrafish (hematoxylin eosin). a Male. b Female
Table 1 Range of drugs used in human medicine with similar
results of toxicity (LC50) in zebrafish
Drug Used as
Geladanamycin Antibiotic
Ethanol (Ethyl alcohol) Antiseptic
Dexamethasone (Corticosteroid) Anti-inflammatory
Acetaminophen Analgesic/ antipyretic
Doxorubicin Used in cancer chemotherapy
Aspirin
(Acetylsalicylic acid)
Analgesic / antipyretic /
anti-inflammatory
Amiodarone Antiarrhythmic / potent vasodilator
Tacrine Reversible acetylcholinesterase
inhibitor
Cyclosporine A Immunosupressor drug
Didemnin B Antiviral / immunosuppressor
Source: Adapted from Kari et al. [43] apud Zhang et al. [99]
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Fig. 3 a Vitelline Yolk Injection (24 HPF), Magnifying Glass Nikon SMZ745, 50X; B) Vitelline Yolk Injection (24 h.p.f.), Magnifying Glass Nikon SMZ745, 50X
Fig. 4 a 24 HPF Zebrafish Embryo Brain Injection, Nikon Microscope; b Brain injection of turbo-red substance into a 24 HPF zebrafish embryo;
c Luciferin-labeled 4 T1 tumor cell bioluminescence in 3-month-old animals
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applied to fishing production is attributed to Guo et al.
[35]. They analyzed the protective efficacy of four iron-
related recombinant proteins and their single-walled car-
bon nanotube encapsulated counterparts against the Aero-
monas hydrophila infection in zebrafish. They observed
that the immune response was increased after vaccination.
Guo et al. [34] also studied Edwardsiella tarda which is
an important intracellular pathogenic bacterium that
causes the infectious disease Edwardsiellosis in fish. They
proved that live E. tarda vaccine enhanced innate immun-
ity by metabolic modulation in zebrafish.
Vibrio anguillarum, a bacterium that causes vibriosis,
was also studied by Ye et al. [98] who observed the mater-
nal transfer and protection role in zebrafish offspring fol-
lowing vaccination of the brood stock with a live attenuated
V. anguillarum vaccine. They proved that the development
of immune cells was enhanced and the maternally-derived
antibody could protect early embryos and larvae from the
attack of specific pathogens via vaccination with a live at-
tenuated vaccine. Furthermore, Liu et al. [50] analyzed the
profiling immune response in zebrafish intestine, skin,
spleen and kidney when immersion vaccinated was used
with a live attenuated V. anguillarum vaccine. Immersion,
or bath vaccination, is a common practice in aquaculture,
because of it being convenient as mass vaccination giving
sufficient protection. The fish is submerged in water with a
sub lethal concentration of the bacteria for a specific time.
Liu et al. [50] observed that antibodies were either pro-
duced at antigen-contact tissues or in immune organs.
Zhang et al. [101] studied Th17-like immune response in
fish mucosal tissues after administration of live attenuated
V. anguillarum via different vaccination routes. When com-
pared to injection vaccination, immersion vaccination elic-
ited intense Th17-like immune responses in the gut tissue
of zebrafish. Vibrio vulnificus, that is an aquatic pathogen
that can cause primary sepsis and soft tissue infection, was
also tested during an experimentation of zebrafish’s reac-
tion to vaccine. It was concluded that CpG oligodeoxynu-
cleotides, a type of essential immunomodulators, protected
zebrafish against Vibrio vulnificus induced infection [15].
Francisella noatunensis is a bacterium that causes granu-
lomatous disease in freshwater and marine fish, and remains
an unsolved problem for the aquaculture sector as no effi-
cient vaccines are yet available. Lagos et al. [46] studied the
immunomodulatory properties of Concholepas concholepas
hemocyanin against francisellosis in a zebrafish model, prov-
ing that his adjuvant was a potential one for aquaculture vac-
cines. Moreover, Brudal et al. [11] observed that vaccination
with outer membrane vesicles from F. noatunensis reduced
the development of francisellosis in a zebrafish model.
Streptococcus sp. has also been studied with the Zebra-
fish model. Streptococcus parauberis is the major infectious
agent of streptococcosis in olive flounder (Paralichthys oli-
vaceus). Kim et al. [45], studying the identification of novel
immunogenic proteins against S. parauberis by reverse vac-
cinology using zebrafish model, identified 41 vaccine candi-
dates against S. parauberis. Furthermore, Streptococcus
iniae was studied by Membrebe et al. [58] testing the pro-
tective efficacy of Streptococcus iniae derived enolase
against Streptococcal infection in zebrafish model. In that
study, enolase protein was evaluated to induce cross-
protective immunity against S. iniae and S. parauberis
which are major pathogens causing streptococcosis in fish.
Further to the aforementioned examples, many other dis-
eases have been investigated with the Zebrafish model. For
example, Rhabdovirus, which is one of the most important
diseases in salmonids, is a virus that causes hemorrhagic
viral septicemia [44, 64]. Listeria monocytogenes [19, 20];
Piscirickettsia salmonis which causes salmonid rickettsia
sepsis (Tandberg et al. [83]); and in adjuvant test to im-
prove the efficacy of vaccines [44], among others [82].
Animals and human vaccines
The zebrafish model has been used not only in aquacul-
ture, but also in veterinary and human medicine. So far,
it has become one of the major model systems used in
modern biomedical research [51]. According to Torraca
et al. [86], zebrafish can be also used as a model for
pathogenesis and host defense, modeling many human
diseases, such as tuberculosis, Staphylococcus aureus and
Shigella infection, among others, as well as model to in-
vestigate immune cells, infection and inflammation of
different kind of human diseases.
Torraca et al. [86] posited that zebrafish could also be used
as a model for Tuberculosis which is a devastating infectious
disease worldwide and with no current prospect of efficient
prevention. Tuberculosis is an infectious disease caused by
bacilli from theMycobacterium tuberculosis complex. It is es-
timated that up to one third of the world’s population is in-
fected with M. tuberculosis and have active tuberculosis,
which often develops decades after the primary infection.
Annually about two million people perish of tuberculosis
and, so far, due to the lack of well-established animal models,
such a disease has been difficult to study [51].
An infection by Mycobacterium marinum in adult zeb-
rafish resembles that of human tuberculosis, as demon-
strated by Myllymäki et al. [62]. Those authors proved
that the M. marinum infection model in adult zebrafish
was suitable for preclinical screening of tuberculosis im-
mune’s responses and vaccines. It was also a promising
new model for tuberculosis vaccine research, including
the pre-clinical identification of vaccine antigens [16, 17,
36, 41, 61, 67];). Other species of Mycobacterium have also
been studied, such as M. bovis [52, 73] and M. abscessos
[7]. M. bovis is most common in cattle, but also affects
humans. M. bovis Bacillus Calmette-Guérin vaccine is cur-
rently available as a prophylactic tool for preventing the
disease. It has been shown to be efficient in preventing
Bailone et al. Laboratory Animal Research           (2020) 36:13 Page 6 of 10
disseminated forms of tuberculosis in children; however,
its efficiency is limited in areas where individuals have had
prior exposure to environmental mycobacteria, and its ef-
ficacy decreased with a host’s age [55].
Moreover, teleost models offer an expanding platform for
the understanding of mycobacterial infections and those
mechanisms that offer the greatest potential to enhance host
protection [37]. The models make it possible to screen the
host and bacterial factors that modify the disease and facili-
tate the search for new therapeutic agents. It has recently
been shown that zebrafish can also be used for the potential
screening of DNA-based vaccines and, in particular, for iden-
tifying novel antigens protecting against mycobacteria [67].
Therefore, using the Zebrafish model is expected to acceler-
ate the understanding of the pathogenesis of tuberculosis
which would lead to the development of better vaccines. Yet,
the usefulness of this model is not limited to tuberculosis,
which as seen before it could benefit research for many other
important infectious diseases [51].
Similarly, this model also helps to elucidate bacterial
infections in animals and humans by Aeromonas hydro-
phila [91], Pseudomonas aeruginosa [74], Escherichia coli
nonpathogenic [63], E. coli CFT073 [95], Listeria mono-
cytogenes [80, 81], Myroides odoratimimus [72], Crono-
bacter turicensis [25], Streptococcus agalactiae [70, 96],
Streptococcus iniae and Streptococcus pyogenes [59, 76,
77], among others [12, 85].
Shigella is a major cause of dysentery worldwide, ac-
counting for up to 165 million cases of shigellosis each year
[23]. Yet, despite there not existing vaccine available as yet,
the human and animal challenge–rechallenge trials with
virulent Shigella as well as observational studies in Shigella-
endemic areas are promising. The incidence of the disease
decreased following Shigella’s infection which pointsto a
biological feasibility of a vaccine [54]. Phalipon et al. [71] as
well as Mani et al. [54] proposed that adult zebrafish could
be used to study the immune response to Shigella, which is
crucial to understanding the crosstalk between Shigella and
T-lymphocytes [75] thus this being relevant in the develop-
ment of vaccine strategies. Studies have also been con-
ducted with Zebrafish model to promote a vaccine against
Salmonella, which produces gastroenteritis that causes
massive morbidity and mortality in adults and children in
developing countries. Howlader et al. [39] proved that zeb-
rafish was an excellent model for the study of vaccines
using successive immersion triple vaccines with the single
serotype Salmonella. Typhimurium and Salmonella entere-
ditis induced protective efficacy against a high dose (108
CFU/ml) of infection by these pathogens.
Other microorganisms of importance such as fungi
which can cause pathologies in humans, such as Candida
albicans [10], Cryptococcus neoformans [8, 84] and Mucor
circinelloides [90] have also been the subject of study with
teleosts. In addition, viruses such as Herpes simplex [13,
31]; human norovirus [88]; Vesicular stomatitis [33]; hepa-
tite C [21, 22]; Chikungunya [1, 9, 14, 68]; Sindib [69] and
Influenza A [30] are some of the human viruses already
studied by the zebrafish model in both embryos and larvae.
Conclusions
The use of the Zebrafish model for the production of
vaccines with application for both animals and humans,
despite already being a reality, is still underused. This
model is an important tool for the development of new
safe vaccines against diseases which do not yet have pre-
ventive treatment, or for which the existing vaccines are
not so effective. Thus, previous screening tests with zeb-
rafish have been proven to be effective in preliminary
phases prior to testing with mammalians. Despite the
evidence from the literature indicating that science in
this field is in its infancy, when compared to other ani-
mal models used in research, teleost models have proved
to be effective in the elucidation of the infection and im-
munological responses to the diverse animal and human
pathogens. In addition, the reduced financial cost and
time frame needed for testing are another attractive re-
garding the use of zebrafish. Thus, it is expected its use
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